Want to see RADX full AI Analyst Report?

Radiopharm Theranostics Limited Sponsored ADR (RADX) Revenue

63 Followers

Radiopharm Theranostics Limited Sponsored ADR Revenue

Radiopharm Theranostics Limited Sponsored ADR had a revenue of 1.40M in the quarter ending Jun 30, 2025, with 3.07%. This bring the company's revenue in the last twelve months to 2.76M, Decreased 103.07%. In the fiscal year ending Jun 30, 2025, Radiopharm Theranostics Limited Sponsored ADR had annual revenue of 2.71M with -25.49% growth.

Revenue (ttm)

2.76M

Revenue Growth

-19.76%

P/S Ratio

10.41

Revenue/Employee

$193,386

Employees

Market Cap

$28.18M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Jun 30, 2025	2.71M	-926.02K	-25.49%
Jun 30, 2024	3.63M	3.33M	+1,114.27%
Jun 30, 2023	299.23K	290.40K	+3,288.38%
Jun 30, 2022	8.83K	-283.53K	-96.98%
Jun 30, 2022	292.36K	―	―